Naomi Fried PhD, a national thought leader on healthcare innovation, is founder and CEO of Health Innovation Strategies. Naomi was previously Biogen’s first VP of Innovation and External Partnerships where she developed Biogen’s “innovation beyond the molecule” strategy to deliver non-pharmacological value to patients and providers. Prior to Biogen, Naomi was the first Chief Innovation Officer at Boston Children’s Hospital (BCH). At BCH, Naomi built and led the Innovation Acceleration Program, which focused on enhancing the innovation culture, improving care quality, and assisting the hospital in shaping the future of health care. The Innovation Acceleration program supported strategic innovation initiatives, resourced grass roots innovation, and identified unmet innovation opportunities. Naomi oversaw the creation and administration of the Innovestment Seed Grant program which supported 37 projects and the FastTrack Innovation in Technology (FIT) Program which developed 9 novel clinical software solutions and mobile apps. She also initiated and led the development of BCH’s telehealth strategy. Before moving to the Boston area, Naomi was the VP of Innovation and Advanced Technology in Kaiser Permanente's (KP) Program Offices where she led an effort to identify and assess emerging health care technologies and chaired the board of its internal Innovation Fund for Technology. She formed KP’s Telehealth Working Group and was involved in the start-up and governance of KP’s Innovation Lab, the Sidney R. Garfield Center for Health Care Innovation. She was the Managing Director of the Archimedes Project. Naomi writes and speaks nationally and internationally on innovation and digital health. Naomi received her Ph.D. in Materials Science from MIT and her B.S. in Chemistry from the University of California, Berkeley.